JP Stock MarketDetailed Quotes

4574 Taiko Pharmaceutical

Watchlist
  • 321
  • +3+0.94%
20min DelayMarket Closed Dec 25 15:30 JST
16.25BMarket Cap-4.21P/E (Static)

Taiko Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taiko Pharmaceutical FY2024 9-Month Earnings Date

Currency：JPYNov 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
4.58B
--
+3.67%
NI to Common Holders
--
714.00M
--
+227.05%
Analyst Rating
No Data

Taiko Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.680B--
Feb 13, 20252024/Q4-- / 1.974B--
Nov 8, 20242024/Q31.719B / ----
May 10, 20242024/Q11.377B / ----
Nov 10, 20232023/Q31.929B / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.680B--
Feb 13, 20252024/Q4-- / 1.974B--
Nov 8, 20242024/Q31.719B / ----
May 10, 20242024/Q11.377B / ----
Nov 10, 20232023/Q31.929B / ----

Unlock Free Earnings Estimates

Taiko Pharmaceutical Earnings Reports

  • Taiko Pharmaceutical: Consolidated financial results report for the 3rd quarter of the fiscal year ending 2024/12 (FY2024)

    Nov 8 01:30 ET

  • Taiko Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)

    Nov 8 01:30 ET

  • Taiko Pharmaceutical: Consolidated financial statements for the second quarter (interim period) of the fiscal year ending December 2024 (FY2024).

    Aug 14 23:00 ET

  • Taiko Pharmaceutical: Confirmatory letter.

    Aug 9 02:34 ET

    • Read more

    Heat List
    JP
    Overall
    Symbol
    Price
    % Chg

    No Data